M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings
Diana Huis in ʼt Veld,Diana Huis in ʼt Veld,Diana Huis in ʼt Veld,Eric Balestre,Jozefien Buyze,Joris Menten,Antoine Jaquet,David A. Cooper,François Dabis,Constantin T. Yiannoutsos,Lameck Diero,Portia Mutevedzi,Portia Mutevedzi,Matthew P. Fox,Matthew P. Fox,Eugène Messou,Christopher J. Hoffmann,Hans Prozesky,Matthias Egger,Matthias Egger,Jennifer Hemingway-Foday,Robert Colebunders,Robert Colebunders +22 more
TL;DR: Different ART regimens have different effects on body weight change, and body weight loss after 1 year of treatment in patients on stavudine might be associated with lipoatrophy.
Journal ArticleDOI
Life expectancy trends in adults on antiretroviral treatment in South Africa.
Leigh F. Johnson,Olivia Keiser,Matthew P. Fox,Matthew P. Fox,Frank Tanser,Morna Cornell,Christopher J. Hoffmann,Hans Prozesky,Andrew Boulle,Mary-Ann Davies +9 more
TL;DR: Although life expectancies in South African ART patients have improved over time, these improvements are not observed after controlling for changes in baseline CD4+ cell count and ART duration, which suggests that changes in clinical practice and programme scale have had little impact on ART mortality in South Africa.
Journal ArticleDOI
Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa
Denise Evans,Rebecca Berhanu,Faith Moyo,Arthemon Nguweneza,Lawrence Long,Matthew P. Fox,Matthew P. Fox +6 more
TL;DR: In patients with an elevated viral load on second-line ART electronic adherence monitoring was associated with a modest, but not significant, improvement in viral suppression.
Journal ArticleDOI
The right combination - treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa.
Kamban Hirasen,Denise Evans,Mhairi Maskew,Ian Sanne,Kate Shearer,Caroline Govathson,Given Malete,Sheryl A. Kluberg,Matthew P. Fox +8 more
TL;DR: Fixed-dose combination single-pill regimens may have a role to play in supporting patient adherence and medical monitoring through improved medical visit attendance and may potentially improve treatment outcomes later on in treatment.
Journal ArticleDOI
Improved simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE II): protocol for a randomized evaluation
Sydney Rosen,Sydney Rosen,Mhairi Maskew,Alana T. Brennan,Alana T. Brennan,Matthew P. Fox,Matthew P. Fox,Lungisile Vezi,Peter Ehrenkranz,Willem D F Venter +9 more
TL;DR: SLATE II improves upon the SLATE I study by reducing the number of reasons for delaying ART initiation and allowing more patients with TB symptoms to start ART on the day of diagnosis, and can readily be adopted in other settings without investment in additional technology.